6 Key Elements of Successful Drug & Device Development in Europe
Challenges of Complying with EMEA and Country-specific Regulations
Navigating EMEA and Country-specific regulations is both confusing and a mammoth task. The EU regulatory system has around 50 regulatory authorities for 31 different countries, making it difficult to understand exactly where to begin when trying to get your product approved and marketed in Europe.
In this guide we discuss:
- An insider’s view of what companies who successfully navigate this process do correctly.
- How one element of the approval process impacts some or all other pieces of the puzzle.
- What core development components to consider before starting the drug & device approval process or bringing it to market.
Submit the form and download now.
Related Resources
The Cost of Poor Project Management
Project Management isn’t for the faint of heart. There is a shockingly high rate of project failure… but on the other hand, great project management can be a key differentiator that leads a company...
Successfully Passing MHRA Inspections for Overseas Manufacturing Sites
ProPharma offers GMP and GDP compliance services from clinical development to commercial distribution of the products' lifecycle. ProPharma’s Compliance and Quality team completed the first on-site...
Navigating the Generic Drug Application and Approval Process
Navigating the generic drug application and approval process can be challenging. From pre-filing through post-approval, find out exactly what needs to be done for your Abbreviated New Drug...